Navigation Links
RBC Life Sciences and MPM Medical Inc. Donate 100,000 Sterile Wound Care Dressings to Help Haitian Earthquake Survivors

IRVING, Texas, Feb. 3 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC Bulletin Board: RBCL), a provider of proprietary nutritional supplements, wound care and pain management products, has donated 100,000 sterile dressings to help the tens of thousands of Haitian earthquake victims suffering from burns, abrasions, deep wounds and similar injuries.


"Cleaning and properly treating wounds is critical following such a devastating tragedy," said RBC Life Sciences President and CEO John W. Price. "Infected or exposed wounds can trigger life-threatening problems. We're happy to join the global wound care community in providing the care that so many of the survivors need."

Under its MPM Medical brand, RBC Life Sciences specializes in wound care and pain management products. MPM Medical donated 100,000 of its Multilayered Composite Dressings to the Red Cross to be distributed by healthcare professionals on the island nation. Sterile wound care dressings are among the supplies needed to treat the most prevalent wounds suffered during the earthquake.

About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the RBC Life Sciences Web site at and the MPM Medical Web site at

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

SOURCE RBC Life Sciences, Inc.



SOURCE RBC Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
2. Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
3. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
4. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
5. Biovista Inc. Named Top Innovator in Life Sciences
6. Advanced Life Sciences Restanza Shows 100% Survival in Tularemia Pivotal Animal Study
7. Fujirebio Diagnostics Named Life Sciences Company of the Year
8. New Executive Leadership and CEO Announced for BiPar Sciences
9. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
10. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
11. Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities
Post Your Comments:
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... -- The total global healthcare industry is expected to grow at ... America has the highest projected growth at 12.7%, ... ), is second with growth projected at 11.5%. ... expenditure. In 2013-2014, total government funded healthcare was nearly 68%. ... 41.2% in 2013-2014. In real terms, out of pocket expenditure ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology:
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in ... on several models of traditional and far-infrared saunas. , For traditional saunas, ... the most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
Breaking Medicine News(10 mins):